Finance

Lists
Outlook: 16.7% bullish·22.2% bearish
Go to analysis
ALL:NYSE
Allstate Corp
$232.60
+1.38%
(+3.17) 1D
$232.60
0.00% (0.00)
After hours
Closed: Oct 12, 4:00:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALL...
Open
$232.82
High
$233.57
Low
$231.91
Mkt. cap
58.81B
Avg. vol.
2.15M
Volume
0.00
Dividend
1.86%
Quarterly dividend
$1.08
Ex-dividend date
Aug 31, 2026
P/E ratio
4.65
52-wk high
$277.22
52-wk low
$188.08
EPS
$50.06
Beta
0.13
Shares outstanding
252.86M
No. of employees
53K
Open
$232.82
High
$233.57
Low
$231.91
Mkt. cap
58.81B
Avg. vol.
2.15M
Volume
0.00
Dividend
1.86%
Quarterly dividend
$1.08
Ex-dividend date
Aug 31, 2026
P/E ratio
4.65
52-wk high
$277.22
52-wk low
$188.08
EPS
$50.06
Beta
0.13
Shares outstanding
252.86M
No. of employees
53K
News stories
From web sources and news partners
Profile
The Allstate Corporation is an American insurance company, headquartered in Glenview, Illinois since 2022. Founded in 1931 as part of Sears, Roebuck and Co., it was spun off in 1993, but was still partially owned by Sears until it became an independent company completely in June 1995. The company also has personal line insurance operations in Canada. With 2018 revenues of $39.8 billion, Allstate ranked 79th in the 2019 Fortune 500 list of the largest United States corporations by total revenue. Its advertising campaign, in use since 1950, asks, "Are you in good hands?", and the logo portrays a pair of human hands. Wikipedia
About Allstate Corp
CEOThomas J. Wilson
Employees53.2K
FoundedApr 17, 1931
HeadquartersNorthfield Township, Illinois, United States
SectorInsurance
Websiteallstate.com
Analyst ratings
Based on 20 analysts giving stock ratings to ALL in the past 3 months
Buy
Buy
9
Hold
8
Sell
3
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for ALL in the last 3 months.
Highest
Current $232.60
$340.00 (+46.17%)
Average
$269.37 (+15.81%)
Lowest
$215.00 (-7.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Elyse Greenspan
Wells Fargo
Hold
Upgraded
$236.00
+1.5%
10/12/2026
Joshua Shanker
Bank of America Securities
Buy
Maintained
$340.00
+46.2%
10/12/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
$295.00
+26.8%
10/07/2026
Vikram Gandhi
HSBC
Buy
Upgraded
$266.00
+14.4%
10/07/2026
Alex Scott
Barclays
Sell
Maintained
$221.00
-5%
10/07/2026
Bob Huang
Morgan Stanley
Hold
Maintained
$240.00
+3.2%
10/06/2026
Robert Cox CFA
Goldman Sachs
Hold
Maintained
$250.00
+7.5%
10/05/2026
Matthew Heimermann
Citi
Sell
Maintained
$215.00
-7.6%
10/05/2026
Paul Newsome
Piper Sandler
Buy
Maintained
$300.00
+29%
09/28/2026
David Motemaden
Evercore ISI
Hold
Maintained
$262.00
+12.6%
09/21/2026
Meyer Shields
KBW
Sell
Maintained
$250.00
+7.5%
09/18/2026
Kevin Heal
Argus Research
Hold
Downgraded
$238.00
+2.3%
08/27/2026
Michael Zaremski
BMO Capital
Buy
Reiterated
$284.00
+22.1%
08/13/2026
Gregory Peters
Raymond James
Buy
Reiterated
$315.00
+35.4%
08/11/2026
Pablo Singzon
J.P. Morgan
Buy
Maintained
$292.00
+25.5%
08/11/2026
Brian Meredith
UBS
Hold
Reiterated
$275.00
+18.2%
08/10/2026
Mikhail Paramonov
Freedom Capital Markets
Buy
Upgraded
$297.00
+27.7%
08/07/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
08/06/2026
Ryan Tunis
Cantor Fitzgerald
Hold
Maintained
$242.00
+4%
08/05/2026
Harry Fong
Roth MKM
Buy
Maintained
$300.00
+29%
08/06/2026
Jimmy Bhullar
J.P. Morgan
Buy
Maintained
$282.00
+21.2%
07/14/2026
Andrew Andersen
Jefferies
Buy
Maintained
$250.00
+7.5%
05/01/2026
Andrew Kligerman
TD Cowen
Hold
Maintained
-
-
04/02/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
$8.99 / $6.07
+48.03%beat
Revenue / Est. (USD)
18.60B / 17.30B
+7.46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.26B
17.34B
16.94B
18.60B
Cost of goods sold
10.82B
9.93B
11.44B
12.14B
Cost of revenue
10.82B
9.93B
11.44B
12.14B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.16B
2.33B
2.24B
2.17B
Operating expense
2.22B
2.38B
2.29B
2.22B
Total operating expenses
13.04B
12.31B
13.73B
14.35B
Operating income
4.22B
5.03B
3.21B
4.24B
Other non operating income
-
-
-
-
EBT including unusual items
4.82B
4.92B
3.11B
4.14B
EBT excluding unusual items
4.12B
4.94B
3.11B
4.15B
Income tax expense
1.08B
1.09B
650.00M
871.00M
Effective tax rate
22.31%
22.14%
20.91%
21.03%
Other operating expenses
-
-
-
-
Net income
3.75B
3.83B
2.46B
3.27B
Net profit margin
21.71%
22.09%
14.50%
17.59%
Earnings per share
11.17
14.31
10.65
8.99
Interest and investment income
-
-
-
-
Interest expense
-101.00M
-98.00M
-98.00M
-96.00M
Net interest expenses
-101.00M
-98.00M
-98.00M
-96.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.33B
5.14B
3.31B
4.33B
Gain or loss from assets sale
-714.00M
3.00M
-
3.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps